Term
|
Definition
* nurse should look for before: Assess the pain (location, and intensity)
*Focused assessment: Level of consciousness, BP, Pulse, and respirations.
Side effects: Confusion, sedation, respiratory depression, hypotension, constipation, itching, sweating.
when not to give: Hypersensitivity, significant respiratory depression, acute or severe bronchial asthma, paralytic ileus.
contact HCP before giving: head trauma, renal, hepatic, or pulmonary disease, hypothyroidism, seizure disorder, adrenal insufficiency, history of substance abuse, . |
|
|
Term
Naloxone (Opioid Antagonists)
Narcan (Antidotes |
|
Definition
Reversal of CNS depression and respiratory depression because of suspected opioid overdose.
Focused assessment: respiratory rate, rhythm, and depth; pulse, ECG, BP, and level of consciousness. Signs and symptoms of opioid withdrawal, lack of significant improvement. |
|
|
Term
Mixed action (antagonists and agonist)
Pentazocine |
|
Definition
Used as and analgesia during labor, sedation prior to surgery, and supplementation in balanced anesthesia.
Nurse should check BP, pulse and respirations, prior analgesic history, assess risk for opioid addiction, abuse, or misuse prior to administration.
Side effects: Dizziness, euphoria, hallucinations, headache, sedation, nausea.
Seek HCP input before admin: head truma, drug abuse, renal, hepatic or pulmonary disease, hypothyroidism, adrenal insufficiency, liver impairment, alcoholism, undiagnosed abdominal pain. prostatic hyperplasia, or recently received agonists
Nurse wouldn't give if: hypersensitivity, or patient who is dependent on opioids |
|
|
Term
| antimigraine (NSAIDs) Sumatriptan |
|
Definition
Acute treatment of migraine attacks, and acute treatment of cluster headache episodes.
When not to give: ischemic heart disease, uncontrolled hypertension, stroke, peripheral disease, and severe hepatic impairment
Assessment before: pain location, intensity, duration, and associated symptoms(photophobia, phonophobia, nausea, and vomiting) during migraine attack.
assessment after: Monitor BP
Side effects: Dizziness, vertigo, tingling, warm sensation, injection site reaction anaphylaxis
HCP input before: women of reproductive potential, lactating women, cardiovascular risk factors. |
|
|
